MODERATOR
:
SPEAKER
(S):
Jeffrey Winters, MD, Director Therapeutic Apheresis Unit/Transfusion Medicine Fellowship Program, Mayo Clinic-Rochester
Product CD34+ cell content: Factors influencing yields
Dr. Laura Cooling, MD, MS, Associate Professor, University of Michigan
Description
HPC, Apheresis products are the primary source of grafts in autologous and allogeneic adult hematopoietic stem cell transplantation. The quality of the product has impact not only on engraftment but also on the long term outcomes of the patients. This program will focus on different parameters which affect the quality of the products as well as the ways to improve it. In addition, donor characteristics both in autologous and allogeneic setting and their effect on the collection will be reviewed.
-
1. Identify the most critical variables involved in HPC, Apheresis collection
-
2. Recognize issues related to collection of challenging patient/donors
-
3. Identify the patients' outcomes related to the quality of HPC, Apheresis product
-
4. Define methods to improve collection efficiency
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.